What the science is also showing us is that these are organ-protective medications, not simply weight loss drugs
In the article, the various functions of glutathione are described as follows: Clinically, glutathione is thought to critical for the following disease and body processes References Mechanism of Action 1-4 Glutathione has many mechanisms in the body to support its role as an antioxidant, a detoxifier, and its involvement in many enzymatic processes including redox reactions
Final Thoughts The FDAs regulatory updates reshape access to compounded GLP-1 medications , emphasizing patient safety, drug quality, and compliance
however, semaglutide (Wegovy, Ozempic, Rybelsus) and liraglutide (Saxenda) are all FDA-approved
Novo Nordisk A/S Key Target Audience Market Players Investors End-users Government Authorities Consulting and Research Firm Venture capitalists Value-Added Resellers (VARs) Recent Development In January 2023, Semaglutide (Wegovy- Novo Nordisk) has been licensed by the US Food and Drug Administration for the treatment of obesity in pediatric patients aged 12 and above